Navigation Links
Centocor Ortho Biotech Inc. Announces NDA Submission for Abiraterone Acetate for the Treatment of Metastatic Advanced Prostate Cancer
Date:12/20/2010

ed States, Europe and Asia. J&JPRD is focusing its drug discovery and drug development efforts to address unmet medical needs worldwide in a variety of therapeutic areas including cardiovascular and metabolic diseases, oncology, immunology, central nervous system disorders and virology. More information can be found at http://www.jnjpharmarnd.com.

About Ortho Biotech Oncology Research & Development, Unit of Cougar Biotechnology, Inc.

Ortho Biotech Oncology Research & Development, unit of Cougar Biotechnology, Inc., partners with affiliated units and companies in the Janssen Pharmaceutical Companies of Johnson & Johnson, such as Centocor Ortho Biotech Inc. and J&JPRD, in the research and development of oncology and supportive care treatments. 

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Centocor Ortho Biotech Inc., J&JPRD, Janssen-Cilag International NV and/or Johnson & Johnson. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010.  Copies of this Form 10-
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI® Label to Include Inhibition of Structural Damage in Treatment of Psoriatic Arthritis
2. Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotechs New Psoriasis Agent Stelara (ustekinumab) is High
3. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
4. MD+DI, MPMN, and OrthoTec Announce Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices
5. Ascension Orthopedics Implants PyroTITAN™ in France
6. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
7. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
8. Reportlinker adds Europe Orthopedic Devices Market Outlook to 2016
9. Reportlinker Adds Asia-Pacific Orthopedic Devices Market Outlook to 2016
10. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
11. Ascension Orthopedics Announces Implantation of the TITAN™ Modular Total Shoulder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Trace Curry successfully placed one ... In the last month the FDA has approved two intra-gastric balloons, the ... procedures represent the first incisionless, reversible, weight loss procedures available to Americans. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Elizabeth Callahan, MD, founder and ... first in the area to offer RADIESSE® filler treatment for volume loss in the ... of tendons and veins in the hands, delivering smooth, natural-looking results that can last ...
(Date:9/1/2015)... ... ... September is Baby Safety Month, and Lightning Labels wants to ... ones' safety top of mind at all times. , Sponsored by the Juvenile Products ... JPMA's Baby Safety Zone website, this year's theme is A Room with A Safe ...
(Date:8/31/2015)... ... 01, 2015 , ... The PT Outcomes Registry is an organized system for ... patients. The Registry is being developed by the American Physical Therapy Association (APTA). , ... be selected to contribute FOTO Outcomes measures as one of the primary global outcomes ...
(Date:8/31/2015)... ... 31, 2015 , ... ITC Global Translations website, http://www.ITCGlobalTranslations.com ... translation services within the medical and pharmaceutical industries. These are industries that ITC ... , ITC Global Translations specializes in professional translation services for materials used in ...
Breaking Medicine News(10 mins):Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3
... Researchers announced today that a high-density genome wide analysis ... www.adni-info.org) is more than 95% complete and that data ... further analysis. , The ADNI data will be used ... the development of Alzheimer,s disease, which currently affects up ...
... has workers looking over their shoulders according to ... of U.S. workers said their work atmosphere felt ... Tell It Now(SM) survey released by ComPsych today. ... "panicky." ComPsych Corporation is the world,s largest provider ...
... Tampa Bay to Convert 10,000 Regional Physicians to ... RecordsTAMPA, Fla., March 16 /PRNewswire/ -- ... armed with strong Congressional support, today launched a ... Tampa Bay will deploy more than 100 "electronic ...
... Involvement between Hospice Providers and Patient,s Primary PhysiciansALEXANDRIA, Va., ... March 9 issue of Archives of Internal Medicine, ... from feelings of abandonment when a physician who had ... Additionally, when there was no continuity between care ...
... Guidelines in Oncology(TM) for Ovarian Cancer were presented at ... additions to the NCCN Guidelines are a section on ... for recurrence therapy. Robert J. Morgan, MD, of City ... Guidelines that continue to stress early detection of ovarian ...
... Coding, Billing, Reimbursement and Disaster Recovery for ... Ala., March 16 /PRNewswire/ ... that Mobile Emergency Group, P.C., has successfully ... including coding, billing, reimbursement, credentialing and disaster ...
Cached Medicine News:Health News:Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis 2Health News:Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis 3Health News:Work Atmosphere Is Worried, Panicky, Say Majority of U.S. Employees 2Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 2Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 3Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 4Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 5Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 6Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 7Health News:Study Finds that Dying Patients and Families Suffer from Lack of Continuity of Physician Care 2Health News:Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer 2Health News:Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer 3Health News:Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer 4Health News:Mobile Emergency Group Implements DST Health Solutions' Revenue Cycle Management Outsourcing Services 2Health News:Mobile Emergency Group Implements DST Health Solutions' Revenue Cycle Management Outsourcing Services 3
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: